Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome

Human Reproduction

Volumn 20, Issue 9, 2005, Pages 2409-2413

  Vural, Birol ^a   Caliskan, Eray ^a   Turkoz, Erkan ^a   Kilic, Teoman ^a   Demirci, Ali ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Cardiovascular; Metabolic syndrome; PCOS; Risk

Indexed keywords

SEX HORMONE BINDING GLOBULIN;

ADULT; ANTHROPOMETRY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE TOLERANCE TEST; HORMONE DETERMINATION; HUMAN; HYPERANDROGENISM; LINEAR REGRESSION ANALYSIS; LIPID ANALYSIS; METABOLIC SYNDROME X; MORBIDITY; OBESITY; OVARY POLYCYSTIC DISEASE; PREDICTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 24044500327     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/dei100     Document Type: Article

References (33)

1. Apridonidze T, Essah PA, Iuorno MJ and Nestler JE (2005) Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metabi 90(4),1929-1935.
2. Balkau B and Charles MA (1999) Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance. Diabet Med 16,442-443.
3. Bots ML, Hoew AW, Koudstaal PJ, Hofman A and Grobbee DE (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam study. Circulation 96,1432-1437.
4. Brook RD, Bard RL, Glazewski L, Kehrer C, Bodary PF, Fitzman DL, Rajagopalan S (2004) Effect of short term weight loss on the metabolic Syndrome and conduit vascular endothelial function in overweight adults. Am J Cardiol 93(8),1012-1016.
5. Cibula D, Fanta M, Vrbikova J, Stanicka S, Dvorakova K, Hill M, Skrha J, Zivny J and Skrenkova J (2004) The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenemia, SHBG and lipids in PCOS patients. Hum Reprod 20,180-184.
6. Elter K, Imir G and Durmusoglu F (2002) Clinical and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: A randomized controlled trial. Hum Reprod 17,1729-1737.
7. Gallwey FD (1962) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21,1440-1447.
8. Goodman E, Daniels SR, Morrison JA, Huang B and Dolan LM (2004) Contrasting prevalence of and the demographic disparities in the world health organization and national cholesterol education program adult treatment panel III definitions of metabolic syndrome among adolescents. J Pediatr 145,445-451.
9. Guzick DS (2004) Polycystic ovary syndrome. Obstet Gynecol 103, 181-193.
10. Kent SC and Legro SC (2002) Polycystic ovary syndrome in adolescents. Adoles Med 13,73-88.
11. Kohen-Avramoglu R, Theriault A and Adeli K (2003) Emergence of metabolic syndrome in childhood: An epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem 36,413-420.
12. Lakhani K, Hardiman P and Seifalian AM (2004) Intima-media thickness of elastic arteries of young women with polycystic ovaries. Atherosclerosis 175,353-359.
13. Lakhani K, Seifalian AM, Hardiman P (2002) Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 106, 81-85.
14. Legro RS, Finegood D and Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83,2694-2698.
15. Lepor NE (2004) An update on diagnostic criteria for diabetes and the metabolic syndrome. Rev Cardiovasc Med 5,182-185.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28,412-429.
17. Matthews KA, Kuller LH, Sutton-Tyrrell K and Chang Y (2001) Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in helthy women. Stroke 32,1104-1111.
18. Morley JE, Patrick P and Perry III HM (2002) Evaluation of assays available to measure free testosterone. Metabolism 5,554-559.
19. Orio Jr F, Palomba S, Spinelli L, Cascella T, Tauchmanova L, Zullo F, Lombardi G and Colao A (2004a) The cardiovascular risk of young women with polycystic ovary syndrome: An observational, analytical, prospective case control study. J Clin Endocrinol Metab 89,3696-3701.
20. Orio P Jr F, alomba S, Cascella T, de Simone B, di Biase S, Russo T, Labella D, Zullo F, Lombardi G and Colao A (2004b) Early impairment of endothelial structure and function in young normal weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 89,4588-4593.
21. Pierpoint T, McKeigue P, Isaacs A and Jacobs HS (1998) Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51,581-586.
22. Ridker PM, Wilson PW and Grundy SM (2004) Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109,2818-2825.
23. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19, 41-47.
24. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS and Oberfield SE (2003) Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): Comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88,4682-4688.
25. Solomon C, Hu F, Dunaif A, Rich- Edwards J, Stampfer M, Willett W, Speizer F and Manson J (2002) Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87,2013-2017.
26. Stein JH, Douglas PS, Srinivasan SR, Bond G, Tang R, Li S et al. (2004) Distribution and cross-sectional age-related increases of carotid intimamedia thickness in young adults. The Bogalusa Heart Study. Stroke 35,2782-2787.
27. Sutton-Tyrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA and Kuller LH (1998) Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 29,1116-1121.
28. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE and Kuller LH (2000) Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20,2414-2421.
29. Tarkun I, Arslan BC, Canturk Z, Türemen E, Sahin T and Duman C (2004) Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low grade chronic inflammation. J Clin Endocrinol Metab 89,5592-5596.
30. Tiras MB, Yalcin R, Noyan V, Maral I, Yildirim M, Dörtlemez O and Daya S (1999) Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome. Hum Reprod 14,1949-1952.
31. Tracy RP (2003) Inflammation, the metabolic syndrome and cardiovascular risk. Int J Clin Pract Suppl 134,10-17.
32. Wild S, Pierpoint T, McKeigue P and Jacobs H (2000) Cardiovascular disease in women with polycystic ovary syndrome at long term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52,595-600.
33. Yildiz BO, Yarali H, Oguz H and Bayraktar M (2003) Glucose intolerance, insulin resistance and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88,2031-2036.